1. Force T, Hibbert P, Weeks GW, Kemper AJ, Bloomfield P, Tow D, et al. Perioperative myocardial infarction after coronary artery bypass surgery: clinical significance and approach to risk stratification. Circulation 1990; 82:903–12.
2. Stiles QR, Kirklin JW. Myocardial preservation symposium. J Thorac Cardiovasc Surg 1981; 82:870–82.
3. Cummins B, Auckland ML, Cummins P. Cardiac specific troponin Tradioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J 1987; 113:1333–44.
4. Wolf RE, Graeber GM, Burge JR, Deshong JL, Macdonald JL, Zajtchuk R. Evaluation of serum creatine kinase and lactate dehydrogenase in experimental myocardial infarction, atriotomies, and thoracotomies. Ann Thorac Surg 1986; 41:378–86.
5. Griesmacher A, Grimm M, Schreiner W, Muller M. Diagnosis of perioperative myocardial infarction by considering relationship of postoperative electrocardiogram changes and enzyme increases after coronary bypass operation. Clin Chem 1990; 36:883–7.
6. Munzer T, Heim C, Reisen W. Perioperative myocardial infarction and cardiac complications after noncardiac surgery in patients with prior myocardial infarction. III: Troponin T — a significant diagnostic alternative in perioperative myocardial infarction. Anaesthetist 1996; 45:225–30.
7. Uchino T, Belboul A, Roberts D, Jagenburg R. Measurement of myosin light chain I and troponin T as markers of myocardial damage after cardiac surgery. J Cardiovasc Surg (Torino) 1994; 35:201–6.
8. Katus HA, Remppis A, Looser S, Hallermeier K, Scheffold T, Kubler W. Enzyme-linked immunoassay of cardiac troponin T for the detection of acute myocardial infarction. J Mol Cardiol 1989; 21:1349–53.
9. Mair J, Dienstl F, Puschendorf B. Cardiac troponin T in the diagnosis of myocardial injury. Crit Rev Clin Lab Sci 1992; 29:31–57.
10. Pearlstone JR, Carpenter MR, Smillie LB. Amino acid sequence of rabbit cardiac troponin T. J Biol Chem 1986; 261:16795–810.
11. Briggs MM, Schachat F. N-terminal amino acid sequence of three functionally different troponin T isoforms from rabbit fast skeletal muscle. J Mol Biol 1989; 206:245–9.
12. Cohen G, Borger MA, Weisel RD, Rao V. Intraoperative myocardial protection: current trends and future perspectives Ann Thorac Surg 1999; 68:1995-2001.
13. Yau TM, Borger MA, Weisel RD, Ivanov J. The changing pattern of reoperative coronary surgery: trends in 1230 consecutive reoperations J Thorac Cardiovasc Surg 2000; 120:156-14. Onorati F, Renzulli A, De Feo M, et al. Does antegrade cardioplegia alone provide adequate myocardial protection in patients with left stem main disease? J Thorac Cardiovasc Surg 2003; 126:1345-1351.
15. Crittenden MD. Intraoperative metabolic monitoring of the heart: clinical assessment of coronary sinus metabolites Ann Thorac Surg 2001; 72(Suppl):2220-2226.
16. Khabbaz KR, Zankoul F, Warner KG. Intraoperative metabolic monitoring of the heart: online measurement of myocardial tissue pH Ann Thorac Surg 2001;72(Suppl):2227-2234.
17. Siouffi SY, Kwasnik EM, Khouri SF. Methods for the metabolic quantification of regional myocardial ischemia J Surg Res 1987;43:360-378.
18. Vijay P, Szekely L, Aufiero TX, Sharp TG. Coronary sinus adrenomedullin rises in response to myocardial injury Clin Sci 1999; 96:415-420.
19. Koh TW, Hooper J, Kemp M, et al. Intraoperative release of troponin I in coronary venous and arterial blood and its relation to recovery of left ventricular function and oxidative metabolism following coronary artery surgery Heart 1998;80:341-348.
20. Rao V, Ivanov J, Weisel R, et al. Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery Ann Thorac Surg 2001;71:1925-1930.
21. NamayDL, Hammermeister KE, Zia MS,et al. (1982) Effect of perioperative myocardial infarction on late survival in patients undergoing coronary artery surgery. Circulation65:1066–1071.
22. ManganoDT(1994) Beyond CKMB.Biochemical markers for perioperative myocardial infarction. Anesthesiology 81:1317–1320.
23. KatusHA, Schoeppenthau M, Tanzeem A, et al. (1991) Non invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin T. Br Heart J65:259–264.
24. KatusHA, RemppisA, Neumann FJ, et al. (1991) Diagnostic efficiency of troponin T measurements in acutemyocardial infarction. Circulation 83:902–912.
25. JenkinsDP, PugsleyWB, Alkhulaifi AM, et al.(1997) Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypasssurgery. Heart77:314–318.
26. Taggart DP, Bhusari S, Hooper J, et al. (1994) Intermittent ischaemic arrest and cardioplegia in coronary artery surgery: coming a full circle? Br Heart J 72:136– 139.
27. Taggart DP, YoungV, Hooper J, et al.(1994) Lack of cardioprotective efficacy of allopurinol in coronaryarterysurgery. BrHeart J 71:177–181.
28. Boldt J, RotheG, Schindler E, et al.(1996) Can clonidine, enoximone and enalapril help protect themyocardium against ischaemia in cardiacsurgery? Heart 76:207–213.
29. T W KohJ Hooper, M Kemp, F D Ferdinand, D G Gibson, J R Pepper. Intraoperative release of troponin T in coronary venous and arterial blood and its relation to recovery of left ventricular function and oxidative metabolism following coronary artery surgery. Heart 1998; 80:341-348 doi:10.1136/hrt.80.4.341.
30. Francesco Onorati, MDa,, Lucia Cristodoro, MDa, Santo Caroleo, MDb, Antonio Esposito, MDa, Bruno Amantea, MDb, Ermenegildo Santangelo, MDb,Attilio Renzulli, MD, PhDa . Troponin I and Lactate From Coronary Sinus Predict Cardiac Complications After Myocardial Revascularization. Ann Thorac Surg 2007; 83:1016-1023.
31. Vivek Rao, MD, PhDa, Joan Ivanov, RN, MSca, Richard D. Weisel, MDa, Gideon Cohen, MDa, Michael A. Borger, MDa, Donald A.G. Mickle, MDa. Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery. AnnThoracSurg 2001;71:1925-1930.
32. Takayoshi Tsutamoto, Chiho Kawahara, Masayuki Yamaji, Keizo Nishiyama, Masanori Fujii, Takashi Yamamoto, and Minoru Horie Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure. European Journal of Heart Failure (2009) 11, 653–658.
33. PiekarskaML, SzurlejB, LatusekT, WdowikG, DejaMA.Postoperative serum troponin concentration in patients undergoing aortic valve repolacemant does not predictearly postoperative outcome. Kardiol Pol.2013;71(12):1237-44. Doi: 10.5603/KP.a2013.0147.Epub 2013 Jun 25
34. Hernández-Romero D, Vílchez JA, Lahoz Á, et al. High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery. Eur J Cardiothorac Surg. 2014;45(4):733-738. doi:10.1093/ejcts/ezt488
35. Croal BL, Hillis GS, Gibson PH, et al. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation. 2006;114(14):1468-1475. doi:10.1161/CIRCULATIONAHA.105.60237
36. J L Januzzi Jr. HSR Proc Intensive Care Cardiovasc Anesth. 2009;1(3): 22– 32.PMCID: PMC3484554
37. Januzzi JL, Lewandrowski K, MacGillivray TE, Newell JB, Kathiresan S, Servoss SJ,Lee-Lewandrowski E. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol. 2002 May 1;39(9):1518-23.
38. Lurati Buse GA, Koller MT, Grapow M, Bolliger D, Seeberger M, Filipovic M. Theprognostic valueoftroponin releaseafteradult cardiac surgery - a meta-analysis. Eur J Cardiothorac Surg. 2010 Feb;37(2):399-406. doi: 10.1016/j.ejcts.2009.05.054. Epub 2009 Aug 20.
39. Di Stefano S, Casquero E, Bustamante R, Gualis J, Carrascal Y, Bustamante J, Fulquet E, Florez S, Echevarria JR, Fiz L. Plasma troponins as markers of myocardial damage during cardiac surgery with extracorporeal circulation. Tohoku J Exp Med. 2007 Sep;213(1):63-9.
40. Kacila M, Bevilaqua S, Matteucci S, Solinas M, Farnetti A, Jacopo G, Glauber M. Inflammatory and metabolic response of the myocardium during aortic valvesurgeryon thebeatingheart. Bosn J Basic Med Sci. 2006 May;6(2):59-62.
41. Onorati F, Cristodoro L, Caroleo S, Esposito A, Amantea B, Santangelo E, Renzulli A. Troponin I and lactate from coronary sinus predict cardiac complications after myocardial revascularization. Ann Thorac Surg. 2007 Mar;83(3):1016-23.
42. Koh TW, Carr-White GS, DeSouza AC, Ferdinand FD, Hooper J, Kemp M, Gibson DG, Pepper JR. Intraoperative cardiac troponin T release and lactate metabolism duringcoronary artery surgery:comparison of beating heart with conventional coronary arterysurgerywith cardiopulmonary bypass. Heart. 1999 May;81(5):495-500.
43. Andreas Borowski, MD, Muhammed Kurt, MD, Sanchez Calvo, DSc, Gerrit Paprotny, CCP,Erhard Godehardt, DPhil,Jan Fraessdorf, MD, and Ali Ghodsizad, MD. Metabolic monitoring of postischaemic myocardium during intermittent warm blood cardioplegic administration Tex Heart InstJ. 2010;37(2): 184–188 PMCID: PMC2851414
44. Trunk P, Gersak B. Comparison of serum troponin I and plasma lactate concentrations in arrested versus beating-heart aortic valve replacement. J Heart Valve Dis. 2010 Nov;19(6):716-22.
45.Bomfim V, Kaijser L, Olin C. Myocardial protection during aortic valve replacement. Physiological and metabolic effects of selective coronary perfusion on the fibrillating heart. Scand J Thorac Cardiovasc Surg. 1978;12(3):207-12.
46. Maillet JM, Le Besnerais P, Cantoni M, Nataf P, Ruffenach A, Lessana A, Brodaty D.Frequency, risk factors, and outcome of hyperlactatemia after cardiac surgery. Chest. 2003 May;123(5):1361-6.
47. Onorati F, Santini F, Menon T, Amoncelli E, Campanella F, Pechlivanidis K, Faggian G, Mazzucco A. Leukocyte filtration of blood cardioplegia attenuates myocardial damage and inflammation. Eur J Cardiothorac Surg. 2013 Jan;43(1):81-9. doi: 10.1093/ejcts/ezs145. Epub 2012 Mar 30.
48. Guillermo Mojena Morfa, MD, Julio Taín Blázquez, MD, PhD, Ángel M. Paredes Cordero, MD, Horacio Pérez López, MD, PhD, José R. Llanes Echevarría, BS, Lisbeth González González, MD A Comparison of Beating Heart and Arrested Heart Techniques for Mitral Valve Replacement Surgery. MEDICC Review, Winter 2009, Vol 11, No 1 36-41
49. Takayoshi Tsutamoto*, Chiho Kawahara, Masayuki Yamaji, Keizo Nishiyama, Masanori Fujii, Takashi Yamamoto, and Minoru Horie. Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure. European Journal of Heart Failure (2009) 11, 653–658.
50. Jogia PM, Kalkoff M, Sleigh JW, Bertinelli A, La Pine M, Richards AM, Devlin G. NT-pro BNP secretion and clinical endpoints in cardiac surgeryintensive care patients. Anaesth Intensive Care. 2007 Jun;35(3):363-9.
51. PM Kapoor, B Mandal, UK Chowdhury, SP Singh, and U Kiran. J Anaesthesiol Clin Pharmacol. 2011 Apr-Jun; 27(2): 225–232.
52. Moffitt EA, Molnar GD, McGoon DC. Myocardial and body metabolism in fatal cardiogenic shock after valvular replacement. Circulation. 1971Aug;44(2):237-44.
53. Robertson I, Sun YB, MX Li, BD Sykes (2010). "A structural and functional perspective into the mechanism of Ca2+-sensitizers that target the cardiac troponin complex". Journal of Molecular and Cellular Cardiology 49: 1031–1041.
54. Moses, Marsha A.; Wiederschain D.; Wu I.; Fernandez, C.; Ghazizadeh V.; Lane W.; Flynn E.; Sytkowski A.; Tao T.; Langer R. (1999). "Troponin I is present in human cartilage and inhibits angiogenesis". Proceedings of the National Academy of Sciences of the United States of America 96 (6): 2645–2650.
55. Antman EM, Tanasijevic MJ, Thompson B, et al. (October 1996). "Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes". N. Engl. J. Med.335 (18): 1342–9.
56. Ammann P, Pfisterer M, Fehr T, Rickli H (May 2004). "Raised cardiac troponins". BMJ 328(7447): 1028–9
57. Tsai SH, Chu SJ, Hsu CW, Cheng SM, Yang SP (March 2008). "Use and interpretation of cardiac troponins in the ED". Am J Emerg Med 26 (3): 331–41.
58. Lim W, Qushmaq I, Devereaux PJ, et al. (2006). "Elevated cardiac troponin measurements in critically ill patients". Arch. Intern. Med. 166 (22): 2446–54.
59. Henry CR, Satran D, Lindgren B, Adkinson C, Nicholson CI, Henry TD (January 2006). "Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning". JAMA 295 (4): 398–402.
60. Satran D, Henry CR, Adkinson C, Nicholson CI, Bracha Y, Henry TD (May 2005). "Cardiovascular manifestations of moderate to severe carbon monoxide poisoning". J. Am. Coll. Cardiol. 45 (9): 1513–6.
61. Bonnefoy E, Godon P, Kirkorian G, Chabaud S, Touboul P (April 2005). "Significance of serum troponin I elevation in patients with acute aortic dissection of the ascending aorta". Acta Cardiol60 (2): 165–70.
62. Needham DM, Shufelt KA, Tomlinson G, Scholey JW, Newton GE (October 2004). "Troponin I and T levels in renal failure patients without acute coronary syndrome: a systematic review of the literature". Can J Cardiol 20 (12): 1212–8.
63. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A (November 2005). "Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis". Circulation 112 (20): 3088–96.
64. Rifai N, Douglas PS, O'Toole M, Rimm E, Ginsburg GS (April 1999). "Cardiac troponin T and I, echocardiographic [correction of electrocardiographic] wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon". Am. J. Cardiol. 83 (7): 1085–9.
65. Neumayr G, Gaenzer H, Pfister R, et al. (February 2001). "Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise". Am. J. Cardiol. 87 (3): 369–71, A10.doi:10.1016/S0002-9149(00)01382-5
66. Urhausen A, Scharhag J, Herrmann M, Kindermann W (September 2004). "Clinical significance of increased cardiac troponins T and I in participants of ultra-endurance events".Am. J. Cardiol. 94 (5): 696–8.
67. Kobayashi S, Tanaka M, Tamura N, Hashimoto H, Hirose S (September 1992). "Serum cardiac troponin T in polymyositis/dermatomyositis". Lancet 340 (8821):726.
68 Erlacher P, Lercher A, Falkensammer J, et al. (April 2001). "Cardiac troponin and beta-
type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis". Clin. Chim. Acta 306 (1-2): 27–33
69 Fleming SM, O'Gorman T, Finn J, Grimes H, Daly K, Morrison JJ (November 2000). "Cardiac troponin I in pre-eclampsia and gestational hypertension". BJOG 107(11): 1417–20.
70 Morton A (July 2004). "Raised cardiac troponins: troponin is raised in pre-eclampsia". BMJ329 (7457): 111.
71 Gaze DC,Collinson PO; Collinson, PO (December 2005). "Cardiac troponins as biomarkers of drug- and toxin-induced cardiac toxicity and cardioprotection.". Expert Opin Drug Metab Toxicol. 1 (4): 715–25.
72. Melanson SE, Tanasijevic MJ, Jarolim P (October 2007). "Cardiac troponin assays: a view from the clinical chemistry laboratory". Circulation 116 (18): e501–4.
73. Collinson PO, Boa FG, Gaze DC (September 2001). "Measurement of cardiac troponins".Ann. Clin. Biochem. 38 (Pt 5): 423–49.
74. Zethelius B, Johnston N, Venge P (February 2006). "Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study". Circulation113 (8): 1071–8.
75. Willott RH, Gomes AV, Chang AN, Parvatiyar MS, Pinto JR, Potter JD (May 2010). "Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function?". J. Mol. Cell. Cardiol. 48 (5): 882–92.
76. Myocardial lactate metabolism: evidence of lactate release during net chemical extraction in man. Gertz, E.W., Wisneski, J.A., Neese, R., Bristow, J.D., Searle, G.L., Hanlon, J.T. Circulation (1981.